(Q66921031)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:476006%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

title

Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:476006%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

Studies in Desferrioxamine and Ferrioxamine Metabolism in Normal and Iron-Loaded Subjects (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

1 June 2023

1 reference

M. R. Summers

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476006

5 July 2022

A. Jacobs

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476006

5 July 2022

D. Tudway

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476006

5 July 2022

P. Perera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476006

5 July 2022

C. Ricketts

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A476006

5 July 2022

language of work or name

English

0 references

publication date

1 August 1979

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:476006%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

31 August 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.1979.tb01167.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1979.tb01167.x/fullpdf

1 June 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

British Journal of Haematology

1 June 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:476006%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:476006%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:476006%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

page(s)

547-555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:476006%20AND%20SRC:MED&resulttype=core&format=json

Distribution of intravenously administered ferrioxamine-59 and ferric N,N'-ethylenebis (alpha imino-2-hydroxy-5-chlorophenylacetate) in rats.

31 August 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Effect of Desferrioxamine and D.T.P.A. in Iron Overload

1 June 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Long-term Chelation Therapy in Thalassaemia Major: Effect on Liver Iron Concentration, Liver Histology, and Clinical Progress

1 June 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamine

1 June 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

THE EFFECT OF DESFERRIOXAMINE ON IRON METABOLISM IN MAN

1 June 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells

1 June 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

The Effect of Desferoxamine on Fibroblasts and Collagen Formation in Cell Cultures

1 June 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine

1 June 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

The metabolism of desferrioxamine B and ferrioxamine B

1 June 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Long-term desferrioxamine therapy in thalassemia

1 June 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat

1 June 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Prevention of iron loading in transfusion-dependent thalassaemia

1 June 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Continuous subcutaenous administration of deferoxamine in patients with iron overload

1 June 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Reassessment of the Use of Desferrioxamine B in Iron Overload

1 June 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

Clinical science and molecular medicine

1 June 2023

19

50

145

White G.P.

1976

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE

1 June 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01167.X

1 June 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:476006%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference